✦ LIBER ✦

Treatment with interferon-α and ribavirin in patients with chronic hepatitis C and persistently normal ALT levels

✍ Scribed by A. Erhardt; A. Maschner-Olberg; D. Häussinger

Book ID: 119526362
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 111 KB
Volume: 32
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(00)81028-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination Treatment of IFNα2band Ribav

Combination Treatment of IFNα2band Ribavirin in Patients with Chronic Hepatitis C and Persistently Normal ALTs

✍ Andreas Erhardt; Ulla Behlen-Wilm; Ortwin Adams; Andreas Donner; Tobias Heintges 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 136 KB

Treatment of patients with chronic hepat

Treatment of patients with chronic hepatitis C and normal ALT levels

✍ Nicholas C. Tassopoulos 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 431 KB

Virological profile over time in patient

Virological profile over time in patients with chronic hepatitis C and persistently normal ALT levels

✍ S. Sookoian; G. Castaño; B. Frider; R. Campos; D. Flichman 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Interferon Alpha-2b and Ribavirin for Pa

Interferon Alpha-2b and Ribavirin for Patients with Chronic Hepatitis C and Normal ALT

✍ Jacobson, Ira M.; Ahmed, Furqaan; Russo, Mark W; Lebovics, Edward; Dieterich, Do 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

Viral kinetics during antiviral therapy

Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels

✍ Bernd Kronenberger; Eva Herrmann; Florence Micol; Michael von Wagner; Stefan Zeu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

Viral kinetics during antiviral therapy

Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels

✍ Claudio Puoti; Lia Bellis; Roberto Castellacci; Fabrizio Montagnese 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 1 views

We read with interest a paper by Kudo et al. published in a recent issue of HEPATOLOGY that compared the predictive power between Japan Integrated Staging (JIS) system and Cancer of the Liver Italian Program (CLIP) system in a large patient cohort with hepatocellular carcinoma (HCC). 1 The authors c